2001
DOI: 10.1212/wnl.57.5.780
|View full text |Cite
|
Sign up to set email alerts
|

Stiff person syndrome

Abstract: In patients with SPS, there is marked intrathecal antibody response against neuronal GAD(65) epitopes, indicating a clonal B cell activation in the CNS. Anti-GAD(65) antibodies at high titers, when confirmed with immunoblots, are highly specific for SPS and appear to impair GABA synthesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
196
2
5

Year Published

2004
2004
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 185 publications
(217 citation statements)
references
References 25 publications
14
196
2
5
Order By: Relevance
“…Since anti-GAD antibodies are unable to cross the blood-brain barrier (18), the intrathecal-produced anti-GAD antibodies not from systemic circulation, are essential for the impairment of CNS. In the present case, anti-GAD-specific IgG index (1.62), an assessment index for intrathecal production of anti-GAD antibody (8), was greater than 1.0, thus lending a strong support for its intrathecal production (8,19). In addition, it has been shown that the characteristics of anti-GAD antibodies are different between type 1 diabetes and SPS: anti-GAD65 antibodies in type 1 diabetes may recognize conformational epitopes in the middle and C-terminus of the protein, whereas in SPS they recognize both the linear and conformational epitopes at Nterminus and C-terminus of GAD65 molecules (9,18,20, and 21).…”
Section: Discussionmentioning
confidence: 76%
“…Since anti-GAD antibodies are unable to cross the blood-brain barrier (18), the intrathecal-produced anti-GAD antibodies not from systemic circulation, are essential for the impairment of CNS. In the present case, anti-GAD-specific IgG index (1.62), an assessment index for intrathecal production of anti-GAD antibody (8), was greater than 1.0, thus lending a strong support for its intrathecal production (8,19). In addition, it has been shown that the characteristics of anti-GAD antibodies are different between type 1 diabetes and SPS: anti-GAD65 antibodies in type 1 diabetes may recognize conformational epitopes in the middle and C-terminus of the protein, whereas in SPS they recognize both the linear and conformational epitopes at Nterminus and C-terminus of GAD65 molecules (9,18,20, and 21).…”
Section: Discussionmentioning
confidence: 76%
“…CSF index for LGI1‐IgG and subclasses as compared to serum was calculated according to the Link formula,12 modified for specific antibodies13, 14:LGI1 IgG titer in CSF/ LGI1 lgG titer in serumCSF Albumin (ng/mL)/ serum Albumin (ng/mL) …”
Section: Methodsmentioning
confidence: 99%
“…Also, detectable levels of Immunoglobulin belonging to the subtype IgG were found in the CSF confirming the infiltration of B-cells (Dalakas et al, 2001;Ishii, 2010). The recent epidemiological studies report the existence of anti-gephyrin, anti-amphiphysin and anti-gamma-aminobutyric acid A receptor-associated protein (GABARAP) antibodies in the disease pathology.…”
Section: Stiff-man Syndrome (Sms)mentioning
confidence: 84%